Product Comparison

Comparison Options

• Print
• Email

McKesson #	981867	304337	952614
Description	TDVAX™ Tetanus and Diphtheria Toxoids Adsorbed 2 Lf - 2 Lf / 0.5 mL Injection 0.5 mL	M-M-R® II Measles, Mumps, and Rubella Vaccine, Preservative Free 1,000 TCID - 12,500 TCID - 1,000 TCID / 0.5 mL Injection 0.5 mL	Gardasil® 9 Human Papillomavirus 9-Valent Vaccine, Recombinant, Preservative Free 20 mcg - 60 mcg / 0.5 mL Injection 0.5 mL
Manufacturer #	13533013101	00006468100	00006412102
Brand	TDVAX™	M-M-R® II	Gardasil® 9
Manufacturer	Grifols Therapeutics Inc (TDVAX)	Merck	Merck
Invoice	TDVAX, SDV 0.5ML (10/PK)	M-M-R II, SDV (10/BX)	GARDASIL 9 HPV VACC, SYR 0.5ML(10/BX)
	Log In to Order	Log In to Order	Log In to Order
Comparison
Application	Td Vaccine	MMR Vaccine	Human Papillomavirus Vaccine (HPV)
Container Type	Single-Dose Vial	Single-Dose Vial	Prefilled Syringe
Country of Origin	Unknown	United States	United States
Generic Drug Code	20835	99568	37568
Generic Drug Name	Tetanus and Diphtheria Toxoids Adsorbed	Measles, Mumps, and Rubella Vaccine, Preservative Free	Human Papillomavirus 9-Valent Vaccine, Recombinant, Preservative Free
NDC Number	13533013101	00006468100	00006412102
Product Dating	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 180 days
Strength	2 Lf - 2 Lf / 0.5 mL	1,000 TCID - 12,500 TCID - 1,000 TCID / 0.5 mL	20 mcg - 60 mcg / 0.5 mL
Type	Intramuscular	Intravenous or Subcutaneous	Intramuscular
UNSPSC Code	51201629	51201628	51201649
User	Indicated for People 7 Years of Age and Older	Indicated for People 12 Months of Age and Older	Indicated for People 9 to 45 Years of Age
Dosage Form	Injection	Injection	Injection
Storage Requirements	Requires Refrigeration	Requires Refrigeration	Requires Refrigeration
Volume	0.5 mL	0.5 mL	0.5 mL
Features and Benefits		Preservative free M-M-R II* is supplied as: (1) a box of 10 single-dose vials of lyophilized vaccine and (2) a box of 10 vials of diluent Store vials at 2 - 8 degrees Celsius (36 - 46 degrees Fahrenheit) The diluent may be stored in the refrigerator with the lyophilized vaccine or separately at room temperature	GARDASIL 9 is a non-infectious recombinant 9-valent vaccine prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58 Each 0.5-mL dose contains approximately 30 mcg of HPV Type 6 L1 protein, 40 mcg of HPV Type 11 L1 protein, 60 mcg of HPV Type 16 L1 protein, 40 mcg of HPV Type 18 L1 protein, 20 mcg of HPV Type 31 L1 protein, 20 mcg of HPV Type 33 L1 protein, 20 mcg of HPV Type 45 L1 protein, 20 mcg of HPV Type 52 L1 protein, and 20 mcg of HPV Type 58 L1 protein Administer GARDASIL 9 intramuscularly as a 0.5-mL dose at the following schedule: 0, 2 months, 6 months Not all vulvar, vaginal, and anal cancers are caused by HPV, and GARDASIL 9 protects only against those vulvar, vaginal, and anal cancers caused by HPV 16, 18, 31, 33, 45, 52 and 58